Spectral AI, Inc. is a predictive artificial intelligence company. The company is headquartered in Dallas, Texas and currently employs 65 full-time employees. The company went IPO on 2021-02-12. The firm's DeepView platform is a predictive device that offers clinicians an objective and immediate assessment of a wound healing potential prior to treatment or other medical intervention. DeepView platform that combines AI algorithms and multispectral imaging (MSI) imaging for an assessment of wound healing potential. The company is non-invasive, non-radiation, non-laser and does not require the use of injectable dye. The DeepView AI- Burn software is used with the DeepView SnapShot imaging device, and it is intended to be used as an adjunctive tool to aid healthcare providers in the assessment of burn wound healing potential by differentiating non-healing from healing burned tissue within an image.
最新の財務諸表(Form-10K)によると、Spectral AI Incの総資産は$0で、純損失は$0です。
MDAIの主要な財務比率は何ですか?
Spectral AI Incの流動比率は0、純利益率は0、1株当たり売上高は$0です。
Spectral AI Incの収益はセグメントまたは地域別にどのように分けられていますか?
Spectral AI Inc の最大収益セグメントは Biomedical Advanced Research and Development Authority で、最新の利益発表における収益は 17,700,000 です。地域別に見ると、United States が Spectral AI Inc の主要市場であり、収益は 19,650,000 です。